Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04777175
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
Sponsor: Yongchang Zhang
View on ClinicalTrials.gov
Summary
In advanced non-small cell lung cancer, there will be some rare mutations, such as ALK, KRAS, etc. The efficacy of these immunotherapies on these different rare mutations has not been reported. Therefore, we conducted this retrospective clinical study to explore the efficacy of immunotherapy for different rare mutations.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
186
Start Date
2023-01-01
Completion Date
2025-01-12
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
DRUG
immunity therapy
The patient receives immunotherapy
Locations (2)
Hunan Cancer Hospital
Changsha, Hunan, China
Hunan Cancer hospital
Changsha, Hunan, China